Polaris Capital在2025年第三季度增持了37.3%的Elevance Health股份，受益于强劲的盈利和收入增长。 Polaris Capital boosted its Elevance Health stake by 37.3% in Q3 2025 amid strong earnings and revenue growth.

Polaris Capital Management在2025年第三季度增持了37.3%的Elevance Health（ELV），目前持有83,941股，市值约2,710万美元;而Tema Etfs LLC收购了4,363股，持股比例提升至6,994股。 Polaris Capital Management increased its stake in Elevance Health (ELV) by 37.3% in Q3 2025, now holding 83,941 shares valued at about $27.1 million, while Tema Etfs LLC acquired 4,363 shares, raising its stake to 6,994. 2025年10月21日,高健康报称Q3收入丰厚,每股6.03美元,粗略估计,收入50.09亿美元,比上一年增加12%。 Elevance Health reported strong Q3 earnings on October 21, 2025, with $6.03 per share, beating estimates, and $50.09 billion in revenue, a 12% year-over-year rise. 该公司总部设在印第安纳波利斯,原为Anthem公司,市场上限为833.36亿美元,P/E比率为15.33,红利收益为1.8%。 The company, based in Indianapolis and formerly Anthem, Inc., has a market cap of $83.36 billion, a P/E ratio of 15.33, and a dividend yield of 1.8%. 分析员保持“等待”共识评级,平均价格目标为400.85美元。 Analysts maintain a “Hold” consensus rating with a $400.85 average price target.